Carasent AB (CARA) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Karasent Q4 report for 2025. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to CEO Daniel Omen and CFO Svein-Martin Bjornstedt. Please go ahead. Good morning and welcome to our presentation of the fourth quarter 2025. I will start with a business update and today a little bit extra about AI again. And then Sir Martin will give a financial update. And as most of you know, we're providing EHR systems for healthcare providers. We're growing quite rapidly at 15%. with more than 90% recurring revenues and a net revenue retention of 110%. Looking a bit at the quarter, We have a strong quarter with high activity, especially given that we have taken almost all of Volvat, so that's Capio Norway online. That's something we're really proud of. It's more than 5 million medical records have been transferred from multiple old systems into our system. So I think it's gone more or less on time and in a really good way. So we're really happy with that. And it gives us an extra strong quarter with some extra high consultancy revenue. Even if that's not our focus and we price it lowly. It's the result of the Volvat implementation mostly. In general, we have a really good improvement in profitability with EBITDA margin of 16% in the quarter. That's up from 5% last year, and there are no adjustments this quarter at all. And we also have a very promising sales pipeline. We've been doing quite a lot to strengthen the sales team and marketing team in Sweden, adding new roles and start working in more in different ways. So really promising start this year and the end of last ...